Hisamitsu Pharmaceutical: [Delayed]Corporate Governance Report
Hisamitsu Pharmaceutical: Notice of obtaining approval for partial changes to the primary palmar hyperhidrosis treatment agent “Apohydrate Lotion 20%” new capacity 18 mL (17.28 g) additional approval matters
Hisamitsu Pharmaceutical: Corporate Governance Report 2025/05/23
Hisamitsu Pharmaceutical: Confirmation
Hisamitsu Pharmaceutical: Internal Control Report - 123rd Issue (2024/03/01 - 2025/02/28)
Hisamitsu Pharmaceutical: Financial Report - 123rd Term (2024/03/01 - 2025/02/28)
Hisamitsu Pharmaceutical: Extraordinary Report
Hisamitsu Pharmaceutical: Notice Regarding Cancellation of Treasury Shares
Hisamitsu Pharmaceutical: Executive Appointments
Hisamitsu Pharmaceutical: Notice regarding cancellation of treasury stock
Hisamitsu Pharmaceutical: Executive personnel
Hisamitsu Pharmaceutical: Salonpas has been certified as the world's No. 1 sales share brand for 9 consecutive years
Hisamitsu Pharmaceutical: Independent Officer Registration Form
Hisamitsu Pharmaceutical: NOTICE OF CONVOCATION OF THE 123RD ANNUAL GENERAL MEETING OF SHAREHOLDERS
Hisamitsu Pharmaceutical: Measures to be provided electronically at the 123rd Annual General Meeting of Shareholders (matters not described in the issuance document)
Hisamitsu Pharmaceutical: Notice of Convocation of the 123rd Annual General Meeting of Shareholders
Hisamitsu Pharmaceutical: Executive Appointments
Hisamitsu Pharmaceutical: [Summary]Consolidated Financial Results for the Fiscal Year Ended February 28,2025 [Japanese GAAP]
Hisamitsu Pharmaceutical: Executive personnel
Hisamitsu Pharmaceutical: Summary of Financial Results for the Fiscal Year Ending February 2025 [Japanese GAAP] (Consolidated)